• Join Our Team
  • Contact Us
McDermott + Bull - Executive Search + Interim Leaders
  • INDUSTRIES
    • Aviation, Aerospace, + Defense
    • Consumer Brands
    • Education, Non-Profit, + Public Entities
    • Essential Services
    • Financial Services
    • Healthcare + Life Sciences
    • Industrial, Manufacturing, + Distribution
    • Private Equity
    • Real Estate
    • Technology
  • SERVICES
    • Executive Search
    • Interim Leaders
    • Performance Coaching
  • ABOUT M+B
    • Our Team
    • Diversity
  • INSIGHTS
Select Page
  • Contact Us
  • Services
    • Executive Search
    • Interim Leaders
    • Performance Coaching
  • Industries
    • Aviation, Aerospace, + Defense
    • Consumer Brands
    • Education, Non-Profit, + Public Entities
    • Essential Services
    • Financial Services
    • Healthcare + Life Sciences
    • Industrial, Manufacturing, + Distribution
    • Private Equity
    • Real Estate
    • Technology
  • About M+B
    • Our Team
    • Diversity
  • Insights
  • Join Us
2024 Top Mergers + Acquisitions In MedTech + Life Sciences

2024 Top Mergers + Acquisitions In MedTech + Life Sciences

by McDermott + Bull | Nov 27, 2024 | Ken Dropiewski, Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski Article

What a difference a year makes. In the first half of 2024, the MedTech sector showed a notable uptick in M&A activity, with 114 acquisitions valued at $40.3 billion — close to last year’s total. Despite fewer venture rounds, funding remained strong at $9.7...
Q1 2024 MedTech Market Analysis

Q1 2024 MedTech Market Analysis

by McDermott + Bull | Jun 25, 2024 | Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article, Technology Article

The JPM Q1 2024 MedTech Licensing and Venture report highlights the first quarter of 2024 and shows promising developments in the MedTech investment landscape. There are indications of a potential recovery and growth compared to previous years. Can we be so lucky?...
Human Capital in the MedTech Industry: A Focus on Talent Acquisition and Retention

Human Capital in the MedTech Industry: A Focus on Talent Acquisition and Retention

by McDermott + Bull | Sep 26, 2023 | Article, Ken Dropiewski, Ken Dropiewski Article

In the ever-evolving landscape of MedTech and Life Sciences, where innovation and technological advancement are at the forefront, success isn’t strictly about the devices themselves, but it’s also about the people who bring them to life. The brilliant minds...
A Conversation on Revolutionizing Vascular Care + Challenging the Medical Field

A Conversation on Revolutionizing Vascular Care + Challenging the Medical Field

by McDermott + Bull | Mar 13, 2023 | Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article

A CONVERSATION WITH RENOWNED VASCULAR SURGEON, DR. FRANK J. VEITH As one of America’s most celebrated surgeons, Dr. Frank Veith’s career was anything but conventional – he’s worked undercover for the CIA, attempted to make Vascular Surgery an independent specialty,...
MedTech + Life Sciences 2023 State of the Market for Executive Hiring

MedTech + Life Sciences 2023 State of the Market for Executive Hiring

by McDermott + Bull | Feb 1, 2023 | Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article

MEDTECH + LIFE SCIENCES OUTLOOK IN 2023 2022 was an interesting year, to say the least. It was the tale of two markets. After the extremely volatile years of 2020 and 2021, no one could have predicted the sheer amount of momentum that lay ahead in 2022. The economy...
2022 Top Mergers + Acquisitions In MedTech + Life Sciences

2022 Top Mergers + Acquisitions In MedTech + Life Sciences

by McDermott + Bull | Nov 24, 2022 | Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article

Heading into 2022, many expected the rapid continuation of strong initial public offerings (IPOs) and merger + acquisition (M+A) activity. Wow, that was off. The underestimated implications of supply chain issues, geopolitical concerns, and Federal Trade Commission...
« Older Entries

Recent Posts

  • McDermott + Bull Places Chief Medical Officer and Executive Vice President at Cardiosense
  • McDermott + Bull Places Senior Vice President, Risk Management, Rivermark Community Credit Union
  • McDermott + Bull Announces Strategic Expansion of Essential Services Practice
  • Aligning Growth with Financial Precision: How an Interim CFO Supported Strategic Planning for a PE-Backed Consumer Packaged Goods Manufacturer
  • Driving Deal Readiness: How an Interim CFO Enabled a Successful Sale for a Retail and Distribution Company

Categories

Copyright 2020 McDermott + Bull, Inc. All rights reserved.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo